Bumper sales of its cannabinoid (CBD) hand sanitiser helped give medical cannabis company Sativa, the firm behind the Goodbody Wellness retail chain, a record month for revenues in June.
The firm, based at Beckington, near Frome, shrugged off the high street meltdown caused by the coronavirus lockdown as consumers and corporate buyers snapped up its CBG and alcohol-based hand sanitisers in response to the pandemic.
Savita owns the Goodbody Botanicals brand, which is available in many high street stores and pharmacies, as well as through its chain of Goodbody Wellness outlets, including in Bath.
Earlier this year it signed a distribution agreement with Alliance Healthcare, the leader in distribution to independent pharmacies across the UK, for the Goodbody Botanicals brand and secured its first product listing with WH Smith Travel.
Today the group said it had recorded a record month of revenues in June through a combination of both CBD and hand sanitiser sales from the Goodbody brand, comprising Goodbody Botanicals and Goodbody Wellness.
A range of sectors such as restaurants, airlines and hotels groups had taken on the Goodbody sanitiser programme to safeguard and protect their customers and staff, it said.
Sativa chief executive officer Henry Lees-Buckley addd: “Through our corporate customers we have achieved very strong hand sanitiser sales to complement our existing CBD sales, which has resulted in a record month for the group.
“We’re very pleased to reach this milestone during these difficult retail trading conditions.”
Sativa’s revenues rose more than five-fold to £1.45m last year. The company, which completed a £1.38m share placement and subscription last December, also post revenues of £360,000 for the first quarter of this year – up 49% on the prior-year. Gross profit came in at £210,000 with a 59% margin – ahead of management expectations.
Details of last month’s sales growth to record levels have not been disclosed.
Savita, which also owns PhytoVista Laboratories, a leading testing facility for cannabis-based CBD products, last month said it planned to become a major player in the fast-growing international cannabinoid (CBD) market after signalling its intention to merge with specialist Canadian business Stillcanna.
Sativa was formed by a group of West of England entrepreneurs as a vehicle for investment in the rapid expanding CBD market. Its aim is to build the UK’s leading CBD wellness brands and develop innovative medicinal and veterinary cannabis products.
